Literature DB >> 24362816

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.

Bryony A Thompson1,2, Amanda B Spurdle1, John-Paul Plazzer3, Marc S Greenblatt4, Kiwamu Akagi5, Fahd Al-Mulla6, Bharati Bapat7, Inge Bernstein8,9, Gabriel Capellá10, Johan T den Dunnen11, Desiree du Sart12, Aurelie Fabre13, Michael P Farrell14, Susan M Farrington15, Ian M Frayling16, Thierry Frebourg17, David E Goldgar18,19, Christopher D Heinen20,21, Elke Holinski-Feder22,23, Maija Kohonen-Corish24,25,26, Kristina Lagerstedt Robinson27, Suet Yi Leung28, Alexandra Martins29, Pal Moller30, Monika Morak22,23, Minna Nystrom31, Paivi Peltomaki32, Marta Pineda10, Ming Qi33,34, Rajkumar Ramesar35, Lene Juel Rasmussen36, Brigitte Royer-Pokora37, Rodney J Scott38,39, Rolf Sijmons40, Sean V Tavtigian19, Carli M Tops11, Thomas Weber41, Juul Wijnen11, Michael O Woods42, Finlay Macrae3, Maurizio Genuardi43,44.   

Abstract

The clinical classification of hereditary sequence variants identified in disease-related genes directly affects clinical management of patients and their relatives. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) undertook a collaborative effort to develop, test and apply a standardized classification scheme to constitutional variants in the Lynch syndrome-associated genes MLH1, MSH2, MSH6 and PMS2. Unpublished data submission was encouraged to assist in variant classification and was recognized through microattribution. The scheme was refined by multidisciplinary expert committee review of the clinical and functional data available for variants, applied to 2,360 sequence alterations, and disseminated online. Assessment using validated criteria altered classifications for 66% of 12,006 database entries. Clinical recommendations based on transparent evaluation are now possible for 1,370 variants that were not obviously protein truncating from nomenclature. This large-scale endeavor will facilitate the consistent management of families suspected to have Lynch syndrome and demonstrates the value of multidisciplinary collaboration in the curation and classification of variants in public locus-specific databases.

Entities:  

Mesh:

Year:  2013        PMID: 24362816      PMCID: PMC4294709          DOI: 10.1038/ng.2854

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  55 in total

1.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

2.  Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.

Authors:  C H M Leenen; W R R Geurts-Giele; H J Dubbink; R Reddingius; A M van den Ouweland; C M J Tops; H M van de Klift; E J Kuipers; M E van Leerdam; W N M Dinjens; A Wagner
Journal:  Clin Genet       Date:  2011-01-13       Impact factor: 4.438

3.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Authors:  Valérie Bonadona; Bernard Bonaïti; Sylviane Olschwang; Sophie Grandjouan; Laetitia Huiart; Michel Longy; Rosine Guimbaud; Bruno Buecher; Yves-Jean Bignon; Olivier Caron; Chrystelle Colas; Catherine Noguès; Sophie Lejeune-Dumoulin; Laurence Olivier-Faivre; Florence Polycarpe-Osaer; Tan Dat Nguyen; Françoise Desseigne; Jean-Christophe Saurin; Pascaline Berthet; Dominique Leroux; Jacqueline Duffour; Sylvie Manouvrier; Thierry Frébourg; Hagay Sobol; Christine Lasset; Catherine Bonaïti-Pellié
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

4.  Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.

Authors:  Elisabeth Mangold; Constanze Pagenstecher; Waltraut Friedl; Micaela Mathiak; Reinhard Buettner; Christoph Engel; Markus Loeffler; Elke Holinski-Feder; Yvonne Müller-Koch; Gisela Keller; Hans K Schackert; Stefan Krüger; Timm Goecke; Gabriela Moeslein; Matthias Kloor; Johannes Gebert; Erdmute Kunstmann; Karsten Schulmann; Josef Rüschoff; Peter Propping
Journal:  Int J Cancer       Date:  2005-09-20       Impact factor: 7.396

5.  Deciphering the colon cancer genes--report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010.

Authors:  Maija R J Kohonen-Corish; Finlay Macrae; Maurizio Genuardi; Stefan Aretz; Bharati Bapat; Inge T Bernstein; John Burn; Richard G H Cotton; Johan T den Dunnen; Thierry Frebourg; Marc S Greenblatt; Robert Hofstra; Elke Holinski-Feder; Ilkka Lappalainen; Annika Lindblom; Donna Maglott; Pål Møller; Hans Morreau; Gabriela Möslein; Rolf Sijmons; Amanda B Spurdle; Sean Tavtigian; Carli M J Tops; Thomas K Weber; Niels de Wind; Michael O Woods
Journal:  Hum Mutat       Date:  2011-03-08       Impact factor: 4.878

6.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.

Authors:  Sven Arnold; Daniel D Buchanan; Melissa Barker; Lesley Jaskowski; Michael D Walsh; Genevieve Birney; Michael O Woods; John L Hopper; Mark A Jenkins; Melissa A Brown; Sean V Tavtigian; David E Goldgar; Joanne P Young; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

9.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.

Authors:  Rebecca A Barnetson; Albert Tenesa; Susan M Farrington; Iain D Nicholl; Roseanne Cetnarskyj; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

Review 10.  Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database.

Authors:  Päivi Peltomäki; Hans Vasen
Journal:  Dis Markers       Date:  2004       Impact factor: 3.434

View more
  184 in total

1.  Lower prevalence of Lynch syndrome in colorectal cancer patients in a Japanese hospital-based population.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Okihide Suzuki; Yusuke Tajima; Noriyasu Chika; Koki Kuwabara; Keiichiro Ishibashi; Katsuharu Saito; Koji Nagata; Hidetaka Eguchi; Junichi Tamaru; Takeo Iwama
Journal:  Surg Today       Date:  2015-08-07       Impact factor: 2.549

Review 2.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

3.  DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.

Authors:  Nicole de Rosa; Miguel A Rodriguez-Bigas; George J Chang; Jula Veerapong; Ester Borras; Sunil Krishnan; Brian Bednarski; Craig A Messick; John M Skibber; Barry W Feig; Patrick M Lynch; Eduardo Vilar; Y Nancy You
Journal:  J Clin Oncol       Date:  2016-07-18       Impact factor: 44.544

4.  Personalized genomic analyses for cancer mutation discovery and interpretation.

Authors:  Siân Jones; Valsamo Anagnostou; Karli Lytle; Sonya Parpart-Li; Monica Nesselbush; David R Riley; Manish Shukla; Bryan Chesnick; Maura Kadan; Eniko Papp; Kevin G Galens; Derek Murphy; Theresa Zhang; Lisa Kann; Mark Sausen; Samuel V Angiuoli; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

5.  Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.

Authors:  Abhijit Rath; Akriti Mishra; Victoria Duque Ferreira; Chaoran Hu; Gregory Omerza; Kevin Kelly; Andrew Hesse; Honey V Reddi; James P Grady; Christopher D Heinen
Journal:  Hum Mutat       Date:  2019-08-17       Impact factor: 4.878

6.  Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes.

Authors:  Brian H Shirts; Eric Q Konnick; Sarah Upham; Tom Walsh; John Michael O Ranola; Angela L Jacobson; Mary-Claire King; Rachel Pearlman; Heather Hampel; Colin C Pritchard
Journal:  Am J Hum Genet       Date:  2018-06-07       Impact factor: 11.025

7.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Authors:  Daniel D Buchanan; Yen Y Tan; Michael D Walsh; Mark Clendenning; Alexander M Metcalf; Kaltin Ferguson; Sven T Arnold; Bryony A Thompson; Felicity A Lose; Michael T Parsons; Rhiannon J Walters; Sally-Ann Pearson; Margaret Cummings; Martin K Oehler; Penelope B Blomfield; Michael A Quinn; Judy A Kirk; Colin J Stewart; Andreas Obermair; Joanne P Young; Penelope M Webb; Amanda B Spurdle
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

8.  Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.

Authors:  Shyam A Patel; Teri A Longacre; Uri Ladabaum; Alexandra Lebensohn; Albert Y Lin; Sigurdis Haraldsdottir
Journal:  Oncologist       Date:  2018-08-02

9.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

10.  The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.

Authors:  Sofia Maia; Marta Cardoso; Paula Paulo; Manuela Pinheiro; Pedro Pinto; Catarina Santos; Carla Pinto; Ana Peixoto; Rui Henrique; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.